Who owns Salix Pharmaceuticals?

Key details on Salix Pharmaceuticals (Ticker: SLXP)

Who owns Salix Pharmaceuticals?

Is SLXP a good stock to own? Find out who bought Salix Pharmaceuticals, who sold Salix Pharmaceuticals (SLXP) stock, and who holds a large position in Salix Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Schroder Investment Management 50.84M $3.40B Sept. 30, 2013
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 26.91M $26.64M March 31, 2015
EQUITEC SPECIALISTS 9.66M $9.66M Dec. 31, 2014
Paulson & Co 5.50M $950.46M March 31, 2015
BNP PARIBAS ARBITRAGE, SNC 4.12M $614.21M Dec. 31, 2013
Pentwater Capital Management 3.77M $651.70M March 31, 2015
Visium Asset Management 3.11M $356.98M Dec. 31, 2014
Bank of America Corporation 2.86M $191.35M Sept. 30, 2013
TIAA-CREF Investment Management 2.59M $405.30M Sept. 30, 2014
Jefferies 2.32M $400.83M March 31, 2015
GOLDMAN SACHS 2.27M $392.95M March 31, 2015
Discovery Capital Management 2.19M $88.58M Dec. 31, 2012
STATE STREET CORPORATION 2.18M $376.36M March 31, 2015
HealthCor Management 2.00M $79.66M June 30, 2011
York Capital Management Global Advisors 1.89M $327.39M March 31, 2015
Damian Sousa 1.87M $125.27M Sept. 30, 2013
JANA PARTNERS 1.86M $213.66M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 1.83M $316.82M March 31, 2015
HealthCor Management 1.82M $99.35M June 30, 2012
Federated Investors 1.81M $162.52M Dec. 31, 2013
BlackRock Fund Advisors 1.76M $303.43M March 31, 2015
Ameriprise Financial 1.75M $215.28M June 30, 2014
VIKING GLOBAL INVESTORS 1.74M $199.78M Dec. 31, 2014
TimesSquare Capital Management 1.67M $173.14M March 31, 2014
Inves 1.64M $188.36M Dec. 31, 2014
Janus Capital Management 1.61M $185.13M Dec. 31, 2014
MORGAN STANLEY 1.57M $180.22M Dec. 31, 2014
S.A.C. Capital Advisors 1.54M $62.26M Dec. 31, 2012
FMR 1.53M $263.85M March 31, 2015
Barclays 1.53M $262.41M March 31, 2015
Franklin Resources 1.51M $100.08M June 30, 2013
OppenheimerFunds 1.51M $173.51M Dec. 31, 2014
Wellington Management Company 1.48M $170.00M Dec. 31, 2014
Vanguard 1.44M $249.24M March 31, 2015

Who sold Salix Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Next Century Growth Investors Sept. 30, 2011 1.61M $47.52M
Nicholas Investments Partners June 30, 2011 5.25M $4.46M
Partner Fund Management March 31, 2011 1.51M $52.72M